---
title: "OSCR stock snaps 6-day slide ahead of Q4 results: Can the rebound survive post-ACA subsidy fears?"
description: "Oscar Health, Inc. (OSCR) ended a six-day losing streak, closing at $12.66, as investors anticipate quarterly results showing revenue growth but widening losses. Q4 revenue is expected to reach $3.12 "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/275399631.md"
published_at: "2026-02-10T04:03:16.000Z"
---

# OSCR stock snaps 6-day slide ahead of Q4 results: Can the rebound survive post-ACA subsidy fears?

> Oscar Health, Inc. (OSCR) ended a six-day losing streak, closing at $12.66, as investors anticipate quarterly results showing revenue growth but widening losses. Q4 revenue is expected to reach $3.12 billion, up from $2.99 billion, while adjusted EBITDA losses may increase to $217.8 million. Analysts have mixed ratings, with a consensus 'Hold' and price targets ranging from $12 to $25. ACA enrollment trends pose risks, but Oscar remains optimistic about profitability by 2026. Retail sentiment on Stocktwits is bullish, with users expressing confidence in the company's potential to exceed expectations.

・The stock posted its best session in nearly a month as investors looked ahead to quarterly results. ・Wall Street expects quarter-on-quarter revenue growth, while losses are projected to widen. ・The company has said previously that it remains confident of returning to profitability in 2026. Shares of Oscar Health, Inc. (OSCR) snapped a six-day losi...

### Related Stocks

- [OSCX.US - Defiance Daily Target 2x Long OSCR ETF](https://longbridge.com/en/quote/OSCX.US.md)
- [OSCG.US - Leverage Shares 2X Long OSCR Daily ETF](https://longbridge.com/en/quote/OSCG.US.md)
- [OSCR.US - Oscar Health](https://longbridge.com/en/quote/OSCR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Oscar Health 第四季度的收入未能達到分析師的預期 | Oscar Health 第四季度的收入和調整後的息税折舊攤銷前利潤（EBITDA）未能達到分析師的預期，收入為 28.1 億美元，而預期為 31.2 億美元。該公司已進入一項 4.75 億美元的循環信貸額度，以增強其資產負債表。對於 20 | [Link](https://longbridge.com/en/news/275445989.md) |
| Oscar Health 預計儘管在 2025 年會有虧損，但在 2026 年將實現增長 | Oscar Health 已獲得 4.75 億美元的循環信貸額度，以增強流動性並支持增長。儘管預計 2025 年收入將增加至 117 億美元，但由於醫療成本高企，公司報告了 3.964 億美元的運營虧損。Oscar 預計 2026 年收入將 | [Link](https://longbridge.com/en/news/275451700.md) |
| 分歧加劇！歐佩克 + 欲 4 月恢復增產，WTI 原油漲勢恐尚未結束！ | 歐佩克 + 計劃在 4 月恢復增產，市場對油價前景存在分歧。WTI 原油近期跌至 62.0 美元上方，連續兩周下跌。美軍將向中東派遣第二艘航母，增加了市場的不確定性。儘管存在供過於求的背景，油價自去年 12 月以來反彈超過 20%。分析認為 | [Link](https://longbridge.com/en/news/275994496.md) |
| 通脹降溫、非農勁爆，美股能否止跌企穩？ | 美國 1 月 CPI 同比降至 2.4%，低於預期，核心 CPI 降至 2.5%，創 2021 年來最低，市場對美聯儲降息預期升溫。美股三大指數漲跌不一，納指小幅下跌但企穩於 24700 點上方。美債殖利率全線下跌，資金回流美債。投資者關注 | [Link](https://longbridge.com/en/news/275994601.md) |
| 儘管面臨奧巴馬醫改的阻力，Oscar Health 的前景超過市場預期，股價上漲 | Oscar Health (OSCR) 的股價上漲，因為該公司提供的 2026 年收入展望超出市場共識，儘管面臨來自奧巴馬醫保保費上漲的挑戰。該公司報告了 2025 年第四季度每股 GAAP 虧損 1.24 美元，收入為 28 億美元，低於 | [Link](https://longbridge.com/en/news/275503652.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.